Intranasal peptide-induced peripheral tolerance: The role of IL-10 in regulatory T cell function within the context of experimental autoimmune encephalomyelitis

Veterinary Immunology and Immunopathology

Volumn 87, Issue 3-4, 2002, Pages 357-372

  Massey, Emma J ^a   Sundstedt, Anette ^b   Day, Michael J ^d   Corfield, Gaynor ^d   Anderton, Stephen ^c   Wraith, David C ^c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Active Biotech Research AB   (Sweden)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Autoimmunity; Experimental autoimmune encephalomyelitis; Interleukin 10; Regulatory T cell

Indexed keywords

ENCEPHALITOGENIC PROTEIN; INTERLEUKIN 10; PROTEIN AC1 9; PROTEIN MOG 35 55; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CELL FUNCTION; CONFERENCE PAPER; DISEASE RESISTANCE; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL MODEL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PROPHYLAXIS; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0036085916     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(02)00068-5     Document Type: Conference Paper

References (99)

1. Hierarchy of the ability of T cell eptopes to induce peripheral tolerance to antigens from myelin
2. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
3. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation
4. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinical distinct models of multiple sclerosis
5. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
6. Peptide-induced T cell regulation of autoimmunity: A role for interleukin 10
7. Isolation of myelin basic protein-reactive T-cell lines from normal human blood
8. MS: A localised immune disease of the CNS
9. IL-10 fails to abrogate experimental autoimmune encephalomyelitis
10. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
11. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice
12. Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor beta-2
13. Staphylococcal enterotoxin B and tumour necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor-beta and interleukin-10
14. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis
15. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis
16. Intranasal administration of insulin peptide B: 9-23 protects NOD mice from diabetes
17. A novel role for TGF-β and IL-10 in the induction of immune privilege
18. High IL-6 and low IL-10 in the CNS are associated with protracted relapsing EAE in DA rats
19. An autoantigenic T cell eptiope forms stable complexes with class II MHC: A novel route for escape from tolerance induction
20. Oral tolerance: Mechanisms and therapeutic applications
21. Two types of mouse helper T cell. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
22. Limited capacity for tolerization of CD4+ T cells specific for pancreatic β cell neoantigen
23. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
24. A CD4+ T cell subset inhibits antigen-specific T cell responses and prevents Colitis
25. MS: A CNS and systemic autoimmune disease
26. Peripheral-antigen-expressing cells in thymic medulla: Factors in self-tolerance and autoimmunity
27. Autoimmune diabetes as a consequence of locally produced interleukin-2
28. The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis
29. Biotechnological agents for the immunotherapy of multiple sclerosis: Principles, problems and perspectives
30. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominent T cell epitope in naïve and sensitized mice
31. Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: A role for intramolecular eptope suppression
32. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin 10 and transforming growth factor β
33. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo
34. Pertussis toxin prevents the induction of peripheral T cell anergy and enhances the T cell response to an encephalitogenic peptide of myelin basic protein
35. T cell tolerance by clonal elimination in the thymus
36. Prevention of experimental myaesthenia gravis by nasal administration of synthetic acetycholine receptor T epitope sequences
37. Analysis of the cytokine mRNA expression in the CNS of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlated with recovery
38. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
39. Conditions that induce tolerance in mature CD4+ T cells
40. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide
41. The molecular regulation of lymphocyte apoptosis
42. Acute experimental autoimmune encephalomyelitis in mice: Adjuvant action of bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the CNS
43. Low avidity recognition of self-antigen by T cells permits escape from central tolerance
44. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naïve and primed adult mice - Implications for autoimmunity
45. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines
46. Control of immune pathology by regulatory T cells
47. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells
48. b mice. Fine specificity and T cell receptor Vβ expresion of encephalitogenic T cells
49. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity
50. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis, oral tolerance: Mechanisms and applications
51. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: Implications for immunotherapy of human autoimmune diseases
52. The anatomy of T cell activation and tolerance
53. Interleukin-10 and the interleukin-10 receptor
54. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by co-transfer of purified CD4+ T cells
55. Virus and autoimmunity: Induction of autoimmune disease in mice by mouse T lymphotropic virus (MTLV) destroying CD4+ T cells
56. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
57. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice
58. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
59. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system
60. Regulatory CD4+ T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis
61. Spontaneous thyroiditis in thymectomized and irradiated Wistar rats
62. Role of transforming growth factor beta in testicular immunosuppression
63. OX-22 high CD4+ T cells induce wasting disease with multiple organ pathology: Prevention by the OX-22 low subset
64. lowCD4 T cells
65. Nasal administration of arthritis-related T cell epitopes of heat shock protein 60 as a promising way for immunotherapy in chronic arthritis
66. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
67. low CDa+ T cells: A population of T cells with immune regulatory activities in vitro
68. Observation on attempts to produce acute disseminated encephalomyelitis in monkeys
69. Immune deviation: The third dimension of nondeletional T cell tolerance
70. The role of different subsets of T regulatory cells controlling autoimmunity
71. Interleukin-10 prevents experimental allergic encephalomyelitis in rats
72. Ionizing radiation and autoimmunity. Induction of autoimmune disease in mice by high dose fractionated total lymphoid irradiation and its prevention by innoculating normal T cells
73. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. Evidence for the active participation of T cells in natural self-tolerance deficit of a T cell subset as a possible cause of autoimmune disease
74. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α chains (CD25)
75. Acceleration of experimental autoimmune encephalomyelitis in interleukin 10-deficient mice: Roles of interleukin 10 in disease progression and recovery
76. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: In vitro selection from unprimed rat T lymphocyte populations
77. Models of T cell anergy: Is there a common molecular mechanism?
78. Positive and negative thymocyte selection induced by different concentrations of a single peptide
79. Regulatory T cells in autoimmunity
80. Certified professionals: CD4+ CD25+ suppressor T cells
81. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein
82. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes
83. Mucosal tolerance and suppression of collagen-induced arthritis induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen expressing a dominant T cell epitope
84. Immunoregulatory mechanisms of the eye
85. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo
86. T cell apoptosis detected in situ during positive and negative selection in the thymus
87. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
88. Characterisation of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats
89. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
90. Cell-cell interactions in the T cell proliferative response
91. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus
92. CD4+ T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice
93. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases
94. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
95. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or delivery of exogenous cytokines using a recombinant vaccinia virus system
96. Suppression of acute and protracted-repalsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats
97. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats
98. 1
99. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81